Muscle relaxants tested to help COVID-19 patients breathe
NCT ID NCT04922814
Summary
This study compared two approaches for helping COVID-19 patients with severe lung failure who needed breathing machines. Researchers tested whether adding muscle relaxants to standard sedation improved oxygen levels and survival compared to sedation alone. The trial involved 40 critically ill patients in intensive care and measured breathing improvement, organ function, and 28-day survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ICU ACQUIRED WEAKNESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Assiut university, faculty of medicine, anesthesia and ICU and pain management department
Asyut, Asyut Governorate, 71515, Egypt
Conditions
Explore the condition pages connected to this study.